{
  "meta": {
    "data_length": 1,
    "message": "Document id doc:ema:bosulif retrieved successfully",
    "request_url": "https://api.moalmanac.org/documents?document_id=doc%3Aema%3Abosulif",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.001719,
    "timestamp_received": "2026-11-09T16:13:49.080537Z",
    "timestamp_returned": "2026-11-09T16:13:49.082256Z",
    "trace_id": "faa73728-59e2-4aee-9229-ae9fbaa9b563"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://moalmanac.org",
    "last_updated": "2026-10-08"
  },
  "data": [
    {
      "id": "doc:ema:bosulif",
      "type": "Document",
      "documentType": "Regulatory approval",
      "name": "Bosulif (bosutinib) [product information]. EMA.",
      "title": null,
      "aliases": [],
      "description": "Pfizer Europe MA EEIG. Bosulif (bosutinib) [product information]. European Medicines Agency website. https://www.ema.europa.eu/en/documents/product-information/bosulif-epar-product-information_en.pdf. Revised August 2025. Accessed August 29, 2025.",
      "urls": [
        "https://www.ema.europa.eu/en/documents/product-information/bosulif-epar-product-information_en.pdf",
        "https://www.ema.europa.eu/en/medicines/human/EPAR/bosulif"
      ],
      "doi": null,
      "pmid": null,
      "extensions": [
        {
          "name": "agent",
          "value": {
            "id": "agent:org:ema",
            "type": "Agent",
            "agentType": "organization",
            "name": "European Medicines Agency",
            "description": "Regulatory agency that approves medicines for use in the European Union."
          },
          "description": "The organization that published this document."
        },
        {
          "name": "company",
          "value": "Pfizer Europe MA EEIG.",
          "description": "The company that manufactures the cancer drug. Only applicable to market authorization documents."
        },
        {
          "name": "drug_name_brand",
          "value": "Bosulif",
          "description": "The brand name of the cancer drug, per this document. Only applicable to market authorization documents."
        },
        {
          "name": "drug_name_generic",
          "value": "bosutinib",
          "description": "The generic name of the cancer drug, per this document. Only applicable to market authorization documents."
        },
        {
          "name": "first_publication_date",
          "value": "2013-04-09",
          "description": "The publication date for the initial version of this document."
        },
        {
          "name": "publication_date",
          "value": "2025-08-26",
          "description": "The publication date for the document."
        },
        {
          "name": "regulatory_identifier",
          "value": null,
          "description": "Identifier assigned by the regulatory agency, such as an FDA application number (e.g. NDA208716, BLA125427) or an EMA product number (e.g. EMEA/H/C/006184)."
        },
        {
          "name": "status",
          "value": "Active",
          "description": "Whether this document is Active or Deprecated within moalmanac-db."
        }
      ]
    }
  ]
}